Clinical Trial Update: TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on TDF and LdT in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Hepatitis B, Chronic | Phase 1, Phase 2 | Status: COMPLETED